SP100 and Herpesviridae infectious disease: With the advent of RNA interference (RNAi)-mediated depletion methodologies, it became apparent that Sp100 acts as a repressor rather than an activator in several herpesvirus infections (18, 41, 50, 51), and the activation seen in earlier studies may be explained by dominant negative effects due to overexpression.